Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-Lift Trial)
Diabetes Care - United States
doi 10.2337/dc18-0165
Full Text
Open PDFAbstract
Available in full text
Date
June 12, 2018
Authors
Publisher
American Diabetes Association